Staar Surgical (STAA) announced that its board of directors has authorized a share repurchase program under which the company may repurchase up to $30M of its outstanding common stock.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- STAAR Surgical’s Earnings Call: Growth Amid Challenges
- Staar Surgical: Hold Rating Amid Strong Q1 Performance and Strategic Adjustments
- Staar Surgical: Hold Rating Amidst Uncertainties and Strategic Adjustments
- Staar Surgical price target raised to $20 from $17 at Canaccord
- Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal